Victimhood and Agency: Gender Strategies by Chinese Women in Light of their Husband’s Homosexuality

2020 ◽  
Keyword(s):  
Chinese Women ◽  
Gender Strategies

Rereading Klein’s “Some reflections on ‘The Oresteia’ ”—the evolution of the mother–daughter relationship in four generations of Chinese women

2020 ◽  
Vol 3 (1) ◽  
pp. 50-59
Author(s):  
Xu Jianqin
Keyword(s):  
Mutual Influence ◽  
Chinese Women ◽  
Chinese History ◽  
Developmental Context ◽  
Child Relationship ◽  
Mother Daughter Relationship ◽  
Foot Binding ◽  
Mother Child Relationship ◽  
Reform And Opening Up ◽  
Opening Up

This article analyses the evolution of the mother–daughter relationship in China, and describes the mothering characteristics of four generations of women, which in sequence includes “foot-binding mothers”, “mothers after liberation”, “mothers after reform and opening up”, and “mothers who were only daughters”. Referring to Klein’s ideas about the mother–child relationship, especially those in her paper “Some reflections on ‘The Oresteia’ ”, the author tries to understand mothers and their impact on their daughters in these various periods of Chinese history, so as to explore the mutual influence of the mother–daughter relationship in particular, and the Chinese cultural and developmental context in general.

High prevalence of the metabolic syndrome in hypertensive rural Chinese women

2008 ◽  
Vol 63 (5) ◽  
pp. 591-598 ◽  
Author(s):  
X. Zhang ◽  
Z. Sun ◽  
D. Zhang ◽  
L. Zheng ◽  
S. Liu ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Chinese Women ◽  
The Metabolic Syndrome ◽  
High Prevalence

Development, Popularization and Application of An Online OvAge Calculator: Qualitative Study Based on the WeChat Mini Program (Preprint)

2020 ◽  
Author(s):  
Wenwen Xu ◽  
Hui Wang ◽  
Zheng Zhu ◽  
Quan Wang ◽  
Jing Jin ◽  
...  
Keyword(s):  
Predictive Model ◽  
Ovarian Reserve ◽  
Chinese Women ◽  
Polycystic Ovary ◽  
Statistical Significance ◽  
Clinical Samples ◽  
Clinical Markers ◽  
Clinical Trial Registry ◽  
Specificity And Sensitivity ◽  
Short Period

BACKGROUND At present, there are many clinical markers and models to assess ovarian reserve, but none of them are ideal. The number of clinical samples is a key factor limiting the specificity and sensitivity of the markers and models, and traditional methods of subject recruitment are time and vigor. In addition, the model of ovarian reserve assessment for Chinese women need to be further explored. OBJECTIVE To explore the possibility of self-reporting for subjects through the WeChat mini program, and provide more data support for further optimization of the OvAge model, and to develop a predictive model of ovarian reserve that is specific to Chinese women. METHODS In this paper, with reference to the existing OvAge model, we developed an online OvAge calculator based on the WeChat mini program for data collection, and then applied the generalized linear model theory to obtain a predictive model of ovarian reserve which is in line with the characteristics of Chinese women. RESULTS Compared to traditional recruiting methods, the online OvAge calculator is able to collect a large number of samples in a short period of time, which is efficient and convenient. Optimized model of estimated OvAge =exp (3.5254-0.001*PRL-0.0231*AMH). This model showed a high statistical significance for each marker included in the equation. We applied the final equation on diminished ovarian reserve and polycystic ovary syndrome datasets and obtained a mean of predicted ovarian age significantly different from the mean of chronological age in both groups. CONCLUSIONS The OvAge calculator based on the WeChat mini program is a novel online subject self-reporting system that can collect many samples in a short period of time, continuously optimize the model and update the mini program version, which is economical, time-saving and efficient., and is worthy of promotion. In addition, the optimized OvAge model is suitable for Chinese women and provides a reference for clinical assessment of ovarian reserve. CLINICALTRIAL The study was approved by Chinese Clinical Trial Registry (registration No. ChiCTR2000037522) and Medical ethics committee of Jiangsu Province Hospital of Chinese Medicine (approved No. 2019NL-152-02).

Sign in / Sign up

Export Citation Format

Share Document